United States: A Cure For Antitrust Standing?

Last Updated: March 14 2013
Article by Barbara T. Sicalides and Deirdre E. McInerney

Recently, the Third Circuit reexamined the test for antitrust standing in Ethypharm S. A. France v. Abbott Laboratories. The importance of the opinion, however, lies not just in the court's affirmation of the multifactor test typically used to analyze antitrust standing, but also in the court's analysis of how the regulatory framework of the pharmaceutical industry plays a role in analyzing the antitrust standing of participants in that industry.

Plaintiff (and appellant) Ethypharm is a French corporation that developed and manufactured the drug Antara. Recognizing the significant time and expense associated with marketing and selling a drug in the United States, Ethypharm granted Reliant Pharmaceuticals an exclusive license to develop, market, and sell Antara in the United States. Reliant also was responsible for obtaining U.S. Food and Drug Administration (FDA) approval for Antara. As permitted by the Food, Drug and Cosmetics Act (FDCA), Reliant relied upon the clinical studies and data for TriCor, a similar, already-approved drug, to obtain approval for Antara. Defendant (and appellee) Abbott Laboratories distributed TriCor in the United States.

Following Antara's FDA approval, Abbott sued Reliant for alleged patent infringement. Reliant and Abbott settled the patent litigation, and Abbott granted Reliant a non-exclusive license for the use of certain patents. The Abbott license, however, limited Reliant's ability to assign it. Several months after settlement, Reliant assigned the rights granted it by Ethypharm to Oscient, another pharmaceutical company. Abbott did not approve of the assignment, and Oscient's ability to sell Antara was limited. Despite Oscient's initial success, Antara's market share declined and it was unable to compete effectively against Abbott.

Ethypharm blamed Antara's failure on Abbott, the patent suit, and the restrictions and royalty payments resulting from the settlement. As a result, Ethypharm asserted claims against Abbott for violations of the Sherman Act and various state laws. The district court denied Abbott's motion to dismiss for lack of antitrust standing, but granted its summary judgment motion determining that Ethypharm did not present sufficient evidence of a causal connection between its alleged antitrust injury and the damage it experienced.

Ethypharm appealed. On appeal the Third Circuit considered the standing arguments first raised in Abbott's motion to dismiss and determined that Ethypharm lacked antitrust standing. The court organized the antitrust standing factors first announced by the Supreme Court in Associated General Contractors of California v. California State Council of Carpenters, into a multifactor test:

(1) the causal connection between the antitrust violation and the harm to the plaintiff and the intent by the defendant to cause that harm, with neither factor alone conferring standing; (2) whether the plaintiff's alleged injury is of the type for which the antitrust laws were intended to provide redress; (3) the directness of the injury, which addresses the concerns that liberal application of standing principles might produce speculative claims; (4) the existence of more direct victims of the alleged antitrust violations; and (5) the potential for duplicative recovery or complex apportionment of damages.

As to Ethypharm, the court only evaluated the second factor, antitrust injury. It concluded that Ethypharm did not suffer antitrust injury and, the absence of this factor alone was sufficient to find an absence of antitrust standing.

The court noted that antitrust injury "is limited to consumers and competitors in the restrained market and to those whose injuries are the means by which defendants seek to achieve their anticompetitive ends."1 It was clear that Ethypharm was not a consumer and the question for the court was whether it fit either remaining definition. Relying on two prior precedents, Barton & Pittinos, Inc. v. SmithKline Beecham Corp. and Carpet Group International v. Oriental Rug Importers Association, Inc.,2 the court determined that Ethypharm was neither a competitor nor one whose injury was the means by which Abbott sought to achieve its anticompetitive ends. Like it did in Barton and Carpet Group, the court considered whether there was cross-elasticity of demand between Ethypharm's and Abbott's products – whether the price of one influences the demand for the other. Here, there was no cross-elasticity of demand. Abbott sells pharmaceutical drugs to consumers, while Ethypharm did not and could not sell a drug to U.S. consumers. Instead, Ethypharm could only sell bulk drug sales from outside the United States to an FDA-approved U.S. reseller. Only Reliant (or it successor), the licensee approved by the FDA to sell Antara, could lawfully sell the drug to consumers in the United States.

Ethypharm argued that Reliant's possession of FDA approval to sell Antara made no difference for purposes of antitrust injury. The court strenuously disagreed, saying that the pharmaceutical industry's stringent requirements create a high legal barrier to entry "that differentiates this case from others in which a manufacturer has a legal right to sell a good in the United States but chooses to utilize an exclusive distributor." Without approval to sell Antara, Ethypharm "is literally not a lawful competitor in the United States ... and cannot be considered a competitor for purposes of antitrust injury." The court also noted that the "inextricably intertwined" exception only has been applied to cases in which the plaintiff and defendant participate in the same relevant market even though they may not be direct competitors. As the court already concluded, Ethypharm and Abbott do not participate in the same relevant market and, therefore, it rejected Ethypharm's argument that its injury was inextricably intertwined with Abbott's conduct.

The court's statement of the multifactor test to evaluate antitrust standing is not new; however, the opinion serves as a reminder that antitrust standing issues must not be overlooked. Plaintiffs and potential plaintiffs cannot ignore antitrust standing. Similarly, potential defendants, when assessing the risk related to their conduct, should assess who the likely complainants might be and whether they would have the requisite antitrust standing. In cases with multiple parties at different levels of the distribution chain or in cases that involve regulated industries such as pharmaceuticals, defendants would be well-served to identify early exactly the role the plaintiff plays in the market.


1 Ethypharm S. A. France v. Abbott Laboratories, No. 11-3602, 2013 U.S. App. Lexis 1567 at *26 (3d Cir. Jan. 23, 2013) (quoting W. Penn Allegheny Health Sys., Inc. v. UPMC, 627 F.3d 85, 102 (3d Cir. 2010).

2 Carpet Group International v. Oriental Rug Importers Association, Inc., 227 F.3d 62 (3d Cir. 2000); Barton & Pittinos, Inc. v. SmithKline Beecham Corp., 118 F.3d 178 (3d Cir. 1997)

This article was published in the Expert Analysis to Competition, Appellate, Life Sciences, IP, New Jersey and Pennsylvania Law360 and respective newsletters on March 12, 2013.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Barbara T. Sicalides
Deirdre E. McInerney
In association with
Related Topics
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions